APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Marburg Hemorrhagic Fever Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Marburg Hemorrhagic Fever Drug Industry Growth and Trends Forecast to 2032

Report ID 174010180119 December 202599 pages

Choose your research edition.

Industry ResearchMarburg Hemorrhagic Fever Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Marburg Hemorrhagic Fever Drug Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Marburg Hemorrhagic Fever Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marburg Hemorrhagic Fever Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Marburg Hemorrhagic Fever Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Marburg Hemorrhagic Fever Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Marburg Hemorrhagic Fever Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Marburg Hemorrhagic Fever Drug include GlaxoSmithKline plc, Vaxart, Inc, Tekmira Pharmaceuticals Corp., Sarepta Therapeutics, Inc., Integrated BioTherapeutics, Inc. and Immunovaccine, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Marburg Hemorrhagic Fever Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Marburg Hemorrhagic Fever Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Marburg Hemorrhagic Fever Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Marburg Hemorrhagic Fever Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Marburg Hemorrhagic Fever Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Marburg Hemorrhagic Fever Drug Market by Company

GlaxoSmithKline plc

Vaxart, Inc

Tekmira Pharmaceuticals Corp.

Sarepta Therapeutics, Inc.

Integrated BioTherapeutics, Inc.

Immunovaccine, Inc.

Marburg Hemorrhagic Fever Drug Segment by Type

TKM-Marburg

Marburg Vaccine

AVI-7288

Others

Marburg Hemorrhagic Fever Drug Segment by Application

Clinic

Hospital

Others

Marburg Hemorrhagic Fever Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marburg Hemorrhagic Fever Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marburg Hemorrhagic Fever Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marburg Hemorrhagic Fever Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Marburg Hemorrhagic Fever Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Marburg Hemorrhagic Fever Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of TKM-Marburg Table 2. Major Company of Marburg Vaccine Table 3. Major Company of AVI-7288 Table 4. Major Company of Others Table 5. Global Marburg Hemorrhagic Fever Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Marburg Hemorrhagic Fever Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Marburg Hemorrhagic Fever Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Marburg Hemorrhagic Fever Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Marburg Hemorrhagic Fever Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Marburg Hemorrhagic Fever Drug Industry Trends Table 27. Marburg Hemorrhagic Fever Drug Industry Drivers Table 28. Marburg Hemorrhagic Fever Drug Industry Opportunities and Challenges Table 29. Marburg Hemorrhagic Fever Drug Industry Restraints Table 30. Global Marburg Hemorrhagic Fever Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Company (2021-2026) Table 32. Global Marburg Hemorrhagic Fever Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Marburg Hemorrhagic Fever Drug Sales Share by Company (2021-2026) Table 34. Global Marburg Hemorrhagic Fever Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Marburg Hemorrhagic Fever Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Marburg Hemorrhagic Fever Drug Major Company Production Sites and Headquarters Table 37. Global Marburg Hemorrhagic Fever Drug Company, Product Type & Application Table 38. Global Marburg Hemorrhagic Fever Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Marburg Hemorrhagic Fever Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Marburg Hemorrhagic Fever Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Marburg Hemorrhagic Fever Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Marburg Hemorrhagic Fever Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Marburg Hemorrhagic Fever Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Marburg Hemorrhagic Fever Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Marburg Hemorrhagic Fever Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Marburg Hemorrhagic Fever Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Marburg Hemorrhagic Fever Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Marburg Hemorrhagic Fever Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Marburg Hemorrhagic Fever Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Marburg Hemorrhagic Fever Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Marburg Hemorrhagic Fever Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Application (2021-2026) & (US$ Million) Table 73. GlaxoSmithKline plc Company Information Table 74. GlaxoSmithKline plc Business Overview Table 75. GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Product Portfolio Table 77. GlaxoSmithKline plc Recent Development Table 78. Vaxart, Inc Company Information Table 79. Vaxart, Inc Business Overview Table 80. Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Vaxart, Inc Marburg Hemorrhagic Fever Drug Product Portfolio Table 82. Vaxart, Inc Recent Development Table 83. Tekmira Pharmaceuticals Corp. Company Information Table 84. Tekmira Pharmaceuticals Corp. Business Overview Table 85. Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Product Portfolio Table 87. Tekmira Pharmaceuticals Corp. Recent Development Table 88. Sarepta Therapeutics, Inc. Company Information Table 89. Sarepta Therapeutics, Inc. Business Overview Table 90. Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 92. Sarepta Therapeutics, Inc. Recent Development Table 93. Integrated BioTherapeutics, Inc. Company Information Table 94. Integrated BioTherapeutics, Inc. Business Overview Table 95. Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 97. Integrated BioTherapeutics, Inc. Recent Development Table 98. Immunovaccine, Inc. Company Information Table 99. Immunovaccine, Inc. Business Overview Table 100. Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio Table 102. Immunovaccine, Inc. Recent Development Table 103. North America Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 105. North America Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2026) Table 106. North America Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America Marburg Hemorrhagic Fever Drug Sales Market Share Forecast by Country (2027-2032) Table 108. North America Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Marburg Hemorrhagic Fever Drug Market Share by Country (2021-2026) Table 111. North America Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Marburg Hemorrhagic Fever Drug Market Share Forecast by Country (2027-2032) Table 113. Europe Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 115. Europe Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2026) Table 116. Europe Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe Marburg Hemorrhagic Fever Drug Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Marburg Hemorrhagic Fever Drug Market Share by Country (2021-2026) Table 121. Europe Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Marburg Hemorrhagic Fever Drug Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Marburg Hemorrhagic Fever Drug Market Share by Country (2021-2026) Table 131. Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Marburg Hemorrhagic Fever Drug Market Share Forecast by Country (2027-2032) Table 133. Latin America Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 135. Latin America Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2026) Table 136. Latin America Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America Marburg Hemorrhagic Fever Drug Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Marburg Hemorrhagic Fever Drug Market Share by Country (2021-2026) Table 141. Latin America Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Marburg Hemorrhagic Fever Drug Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Marburg Hemorrhagic Fever Drug Market Share by Country (2021-2026) Table 151. Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Marburg Hemorrhagic Fever Drug Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Marburg Hemorrhagic Fever Drug Distributors List Table 156. Marburg Hemorrhagic Fever Drug Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Marburg Hemorrhagic Fever Drug Image Figure 2. Global Marburg Hemorrhagic Fever Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marburg Hemorrhagic Fever Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Marburg Hemorrhagic Fever Drug Sales (2021-2032) & (K Units) Figure 5. TKM-Marburg Image Figure 6. Global TKM-Marburg Sales YoY Growth (2021-2032) & (K Units) Figure 7. Marburg Vaccine Image Figure 8. Global Marburg Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. AVI-7288 Image Figure 10. Global AVI-7288 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Marburg Hemorrhagic Fever Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Marburg Hemorrhagic Fever Drug Market Share by Type 2025 VS 2032 Figure 15. North America Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Marburg Hemorrhagic Fever Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Marburg Hemorrhagic Fever Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Marburg Hemorrhagic Fever Drug Market Share by Application 2025 VS 2032 Figure 35. North America Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Marburg Hemorrhagic Fever Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Marburg Hemorrhagic Fever Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Marburg Hemorrhagic Fever Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Marburg Hemorrhagic Fever Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Marburg Hemorrhagic Fever Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Marburg Hemorrhagic Fever Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Marburg Hemorrhagic Fever Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Marburg Hemorrhagic Fever Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Marburg Hemorrhagic Fever Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Marburg Hemorrhagic Fever Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Marburg Hemorrhagic Fever Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Marburg Hemorrhagic Fever Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Marburg Hemorrhagic Fever Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Marburg Hemorrhagic Fever Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Marburg Hemorrhagic Fever Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Marburg Hemorrhagic Fever Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • TKM-Marburg
  • Marburg Vaccine
  • AVI-7288
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • GlaxoSmithKline plc
  • Vaxart, Inc
  • Tekmira Pharmaceuticals Corp.
  • Sarepta Therapeutics, Inc.
  • Integrated BioTherapeutics, Inc.
  • Immunovaccine, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Marburg Hemorrhagic Fever Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Marburg Hemorrhagic Fever Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Marburg Hemorrhagic Fever Drug Market by Type
  6. 1.3.1 TKM-Marburg
  7. 1.3.2 Marburg Vaccine
  8. 1.3.3 AVI-7288
  9. 1.3.4 Others
  10. 1.4 Global Marburg Hemorrhagic Fever Drug Market Size by Type
  11. 1.4.1 Global Marburg Hemorrhagic Fever Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Marburg Hemorrhagic Fever Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Marburg Hemorrhagic Fever Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Marburg Hemorrhagic Fever Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Marburg Hemorrhagic Fever Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Marburg Hemorrhagic Fever Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Marburg Hemorrhagic Fever Drug Industry Trends
  2. 2.2 Marburg Hemorrhagic Fever Drug Industry Drivers
  3. 2.3 Marburg Hemorrhagic Fever Drug Industry Opportunities and Challenges
  4. 2.4 Marburg Hemorrhagic Fever Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Marburg Hemorrhagic Fever Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Marburg Hemorrhagic Fever Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Marburg Hemorrhagic Fever Drug Price (2021-2026)
  4. 3.4 Global Marburg Hemorrhagic Fever Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Marburg Hemorrhagic Fever Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Marburg Hemorrhagic Fever Drug Company, Product Type & Application
  7. 3.7 Global Marburg Hemorrhagic Fever Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Marburg Hemorrhagic Fever Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Marburg Hemorrhagic Fever Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Marburg Hemorrhagic Fever Drug Tier 1, Tier 2, and Tier 3
4 Marburg Hemorrhagic Fever Drug Regional Status and Outlook
  1. 4.1 Global Marburg Hemorrhagic Fever Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Marburg Hemorrhagic Fever Drug Historic Market Size by Region
  3. 4.2.1 Global Marburg Hemorrhagic Fever Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Marburg Hemorrhagic Fever Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Marburg Hemorrhagic Fever Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Marburg Hemorrhagic Fever Drug Forecasted Market Size by Region
  7. 4.3.1 Global Marburg Hemorrhagic Fever Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Marburg Hemorrhagic Fever Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Marburg Hemorrhagic Fever Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Marburg Hemorrhagic Fever Drug by Application
  1. 5.1 Marburg Hemorrhagic Fever Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Marburg Hemorrhagic Fever Drug Market Size by Application
  6. 5.2.1 Global Marburg Hemorrhagic Fever Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Marburg Hemorrhagic Fever Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Marburg Hemorrhagic Fever Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Marburg Hemorrhagic Fever Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Marburg Hemorrhagic Fever Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Marburg Hemorrhagic Fever Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GlaxoSmithKline plc
  2. 6.1.1 GlaxoSmithKline plc Company Information
  3. 6.1.2 GlaxoSmithKline plc Business Overview
  4. 6.1.3 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Product Portfolio
  6. 6.1.5 GlaxoSmithKline plc Recent Developments
  7. 6.2 Vaxart, Inc
  8. 6.2.1 Vaxart, Inc Company Information
  9. 6.2.2 Vaxart, Inc Business Overview
  10. 6.2.3 Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Vaxart, Inc Marburg Hemorrhagic Fever Drug Product Portfolio
  12. 6.2.5 Vaxart, Inc Recent Developments
  13. 6.3 Tekmira Pharmaceuticals Corp.
  14. 6.3.1 Tekmira Pharmaceuticals Corp. Company Information
  15. 6.3.2 Tekmira Pharmaceuticals Corp. Business Overview
  16. 6.3.3 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Product Portfolio
  18. 6.3.5 Tekmira Pharmaceuticals Corp. Recent Developments
  19. 6.4 Sarepta Therapeutics, Inc.
  20. 6.4.1 Sarepta Therapeutics, Inc. Company Information
  21. 6.4.2 Sarepta Therapeutics, Inc. Business Overview
  22. 6.4.3 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  24. 6.4.5 Sarepta Therapeutics, Inc. Recent Developments
  25. 6.5 Integrated BioTherapeutics, Inc.
  26. 6.5.1 Integrated BioTherapeutics, Inc. Company Information
  27. 6.5.2 Integrated BioTherapeutics, Inc. Business Overview
  28. 6.5.3 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  30. 6.5.5 Integrated BioTherapeutics, Inc. Recent Developments
  31. 6.6 Immunovaccine, Inc.
  32. 6.6.1 Immunovaccine, Inc. Company Information
  33. 6.6.2 Immunovaccine, Inc. Business Overview
  34. 6.6.3 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio
  36. 6.6.5 Immunovaccine, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Marburg Hemorrhagic Fever Drug Sales by Country
  2. 7.1.1 North America Marburg Hemorrhagic Fever Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Marburg Hemorrhagic Fever Drug Market Size by Country
  6. 7.2.1 North America Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Marburg Hemorrhagic Fever Drug Sales by Country
  2. 8.1.1 Europe Marburg Hemorrhagic Fever Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Marburg Hemorrhagic Fever Drug Market Size by Country
  6. 8.2.1 Europe Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Marburg Hemorrhagic Fever Drug Sales by Country
  2. 9.1.1 Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Marburg Hemorrhagic Fever Drug Sales by Country
  2. 10.1.1 South America Marburg Hemorrhagic Fever Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Marburg Hemorrhagic Fever Drug Market Size by Country
  6. 10.2.1 South America Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country
  2. 11.1.1 Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Marburg Hemorrhagic Fever Drug Value Chain Analysis
  2. 12.1.1 Marburg Hemorrhagic Fever Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Marburg Hemorrhagic Fever Drug Production Mode & Process
  7. 12.2 Marburg Hemorrhagic Fever Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Marburg Hemorrhagic Fever Drug Distributors
  10. 12.2.3 Marburg Hemorrhagic Fever Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst